Reprotection Commends Florida for Standing Against FDA Rule Change

Reprotection commends a Florida health agency for warning practitioners that, despite the U.S. Food and Drug Administration’s recent rule change regarding mifepristone, providers must still comply with the state’s laws governing abortions. On January 11, the Florida Agency for Health Care Administration released a statement citing two state-level statutes that continue to prohibit retail pharmacies
READ MORE